跳至主要内容
临床试验/NCT03658902
NCT03658902已完成不适用

Retrospective Epidemiological Study on Patients Admitted for Botulism Poisoning in Intensive Care Units in France

Centre Hospitalier le Mans1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2000年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
1
主要终点
Survival

研究概览

简要总结

Botulism poisoning is a rare but serious illness. Because of it's low incidence, it is not well known by physicians. Most studies describing botulism date back to the last century and do not take into account recent advances in intensive care.

The objective of this study is to describe the clinical course, interventions and outcomes of patients with severe botulism poisoning requiring a hospitalisation in an intensive care or high dependancy unit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of botulism
  • Admission in an intensive care or high dependancy unit

排除标准

  • 未提供

结局指标

主要结局

Survival

时间窗: 2000 to 2017

Proportion of patients alive at ICU discharge

次要结局

  • Height(2000 to 2017)
  • History of motor impairment measured by the modified Rankin scale(2000 to 2017)
  • Weight(2000 to 2017)
  • Age(2000 to 2017)
  • History of heart failure measured by the NYHA (New York Health Association) score(2000 to 2017)
  • History of chronic respiratory failure: use of daily oxygen therapy AND/OR non invasive ventilation(2000 to 2017)
  • History of chronic kidney disease measured by the glomerular filtration rate.(2000 to 2017)
  • History of cirrhosis as measured by the CHILD-PUGH score.(2000 to 2017)
  • Source of the contamination(2000 to 2017)
  • Isolated or multiple cases(2000 to 2017)
  • Botulinum Toxin type if identified(2000 to 2017)
  • Severity at ICU admission(2000 to 2017)
  • Mechanical ventilation requirement(2000 to 2017)
  • Invasive mechanical ventilation requirement(2000 to 2017)
  • Non invasive mechanical ventilation requirement(2000 to 2017)
  • Whether or not the patient required a tracheotomy during his ICU stay.(2000 to 2017)
  • Enteral or parenteral nutritional support(2000 to 2017)
  • Number of days of vasopressor support(2000 to 2017)
  • Acute kidney injury measured by maximum serum creatinine during ICU stay.(2000 to 2017)
  • Severe liver failure(2000 to 2017)
  • Whether or not antitoxin was administered to the patient.(2000 to 2017)
  • Whether or not guanidine was administered during ICU stay(2000 to 2017)
  • Healthcare acquired infection(2000 to 2017)
  • Mechanical ventilation related complications.(2000 to 2017)
  • Bedrest complications: bedsores(2000 to 2017)
  • Length of stay.(2000 to 2017)
  • Disability at hospital discharge(2000 to 2017)
  • Bedrest complications: thrombo-embolic complications(2000 to 2017)
  • Disability at ICU discharge(2000 to 2017)
  • Last known disability(2000 to 2017)
  • Survival at hospital discharge(2000 to 2017)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验